Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (K i of 37 M). Crystallographic analysis of chitinaseinhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases.
Introduction
Chitin, a polymer of β(1,4)-linked N-acetylglucosamine (GlcNAc), is an essential structural component of fungal cell walls, the shells of nematode eggs, and arthropod exoskeletons. Family 18 chitinases (CAZY GH 18 [1] ), which degrade this polymer, play key roles in the life cycles of pathogenic fungi [2] [3] [4] , nematodes [5] , malaria [6, 7] , and insects [8] [9] [10] [11] . In addition, a recent study has shown that inhibition of a mammalian chitinase associated with parasitic infections reduces recruitment of inflammatory cells and profoundly dampens T helper 2 (Th2) cellular responses in a murine model of lung inflammation, suggesting that this enzyme may be a potential target for an asthma drug therapy [12] . The enzymes have a conserved (β/α) 8 fold, with a surface groove containing exposed aromatic residues, used for binding the chitin substrate [13] [14] [15] [16] [17] [18] . Family 18 chitinases employ an unusual reaction mechanism, in which the acid protonating the glycosidic bond is a conserved glutamate and the nucleophile is the oxygen of the N-acetyl group on the −1 sugar (the *Correspondence: dava@davapc1.bioch.dundee.ac.uk sugar on the nonreducing end of the glycosidic bond), forming an oxazolinium ion intermediate [13, 15, 19] . A range of chitinase inhibitors has been described, most of which are natural products. Allosamidin is a pseudotrisaccharide that mimics the oxazolinium reaction intermediate, inhibiting family 18 chitinases in the nanomolar-micromolar range [ To aid the development of potent, drug-like, and readily available chitinase inhibitors, we have screened a drug library, leading to the identification of methylxanthines as a potential scaffold. The drugs theophylline, caffeine, and pentoxifylline, which contain the 1,3-dimethylxanthine substructure, were studied in terms of their inhibition and structural mode of binding against a family 18 chitinase from the opportunistic fungal pathogen Aspergillus fumigatus, showing that pentoxifylline inhibits with a K i of 37 M by forming extensive π-π stacking interactions with conserved tryptophans in the active site of this protein. The activity of mammalian chitinases, containing homologous active site amino acid residues in their primary amino acid sequences, are likewise inhibited by these xanthine derivatives.
Results

Inhibitor Screening
A commercially available library of 880 drug molecules was screened at 100 M against a family 18 chitinase, chitinase B1 from A. fumigatus (AfChiB1), using a fluorescent assay ( Figure 1A ). After elimination of apparent false positives (specifically, the hits in the far lower left corner of Figure 1A) , two methylxanthine derivatives, theophylline and pentoxifylline, were identified, possessing a common 1,3-dimethylxanthine substructure, which were the subject of further analyses. Inhibition by theophylline and pentoxifylline, and the closely related methylxanthine caffeine, was initially confirmed by dose-response curves ( Figure 1B) , with IC 50 s ranging from 1500 M (theophylline) to 126 M (pentoxifylline), as presented in Table 1 . Initial enzyme velocity measurements at different concentrations of substrate (5-30 M) and pentoxifylline (0, 60, 50, and 200 M) were used to demonstrate that pentoxifylline is a competitive inhibitor, with a K i of 37 M ( Figure 1C and Table 1) .
Humans possess two family 18 chitinases, a chitotriosidase (hCHT) [26] and acidic mammalian chitinase (AMCase), an enzyme with an unusual acidic pH optimum [27] , the in vivo elaboration of which is probably evolutionarily tied to protective antiparasitic host responses to chitin-bearing pathogens. These enzymes, like AfChiB1, are of the "bacterial" type of family 18 chitinases, possessing a deep catalytic cleft lined with solvent-exposed aromatic residues [17] , sharing 31% and 28% sequence identity with AfChiB1, respectively. Accordingly, the methylxanthines also inhibit the human chitinases, with IC 50 s up to 98 M, for pentoxifylline (Table 1) .
Among their pleiotropic mechanisms of action, methylxanthine derivatives have also variously been reported as phosphodiesterase inhibitors [28, 29] , adenosine receptor antagonists [30] , and inducers of histone deacetylase (HDAC) activity [31] . The inhibition of human phosphodiesterase-4 by theophylline, caffeine, and pentoxifylline was measured using a PDE-SPA assay, and IC 50 s were determined to be in the high M range (Table 1) , consistent with potencies published elsewhere [32] . As a further control, inhibitory potential of these xanthine derivatives was tested against two other glycoside hydrolases, lysozyme (using a fluorescein-based assay) and cellulase from Aspergillus niger (CAZY family GH 8 [1]), using a fluorescent substrate, showing, at most, approximately 1 mM inhibition for cellulase and none for lysozyme (Table 1) . Similarly, allosamidin is known to not inhibit lysozyme [33] . Together these data suggest that there may be a specific AfChiB1-pentoxifylline interaction, prompting us to investigate the precise binding mode.
Structure of Chitinase-Inhibitor Complexes
To determine the mode of binding of theophylline, caffeine, and pentoxifylline to the fungal chitinase, AfChiB1 crystals were soaked with the inhibitors, followed by collection of X-ray diffraction data ( Table 2 ). In addition, a similar procedure was used to obtain a The xanthine ring appears to make favorable π-π stacking interactions with Trp385 (40 Å 2 total buried inhibitor surface), which is conserved in all active family 18 chitinases, and also interacts with the allosamizoline moiety in the allosamidin complex (Figure 2) . Hydrogen bonds are formed with Asp175, Tyr245, and the backbone nitrogen of Trp137, residues all conserved in family 18 chitinases. Further watermediated hydrogen bonds are observed from the O2 oxygen to Asp246 and Arg301. In addition to the methylxanthine in the −1 subsite, an additional ordered Compared to theophylline, caffeine contains an additional 7-methyl group, which appears to increase inhibition 3-fold to an IC 50 of 469 M. In the AfChiB1 complex (Figure 2) , caffeine binds identically to theophylline. This is surprising, as the addition of a 7-methyl group not only results in loss of the hydrogen bond for the xanthine-N7 with Asp175, but also forces Asp175 in the "down" conformation, compared to the "up" conformation in the allosamidin complex (Figure 2) . Similarly, Glu177 moves away to avoid steric clashes of the terminal carboxylate with the N7-methyl. Again, an additional ordered inhibitor molecule is observed in the −3 subsite.
Pentoxifylline is the most potent of the three methylxanthine inhibitors against the fungal chitinase, with a K i of 37 M ( Table 1 ). The AfChiB1-pentoxifylline complex reveals several additional interactions, which may explain the order of magnitude increase in potency compared to caffeine (Figure 2) . Strikingly, Trp137 rotates 93°around χ 1 , sandwiching the xanthine moiety with extensive π-π stacking interactions (approximately 25 Å 2 additional buried surface). The rotation of Trp137 excludes an ordered water molecule seen in the theophylline and caffeine complexes (Figure 2) . Furthermore, the pentoxifylline alkyl-aldehyde tail extends into the −3 subsite, replacing the second ordered xanthine seen in both the theophylline and caffeine complexes, stacking with Trp52 and hydrogen bonding two ordered water molecules (Figure 2) .
To probe the contributions of individual residues in the active site to pentoxifylline binding, interactions between mutant forms of AfChiB1 and the inhibitor were measured with tryptophan fluorescence, exploiting the large conformational change of Trp137 (Table 1 and Figure 1D) . The K d for pentoxifylline with the wild-type enzyme was determined to be 43 ± 10 M, which is in good agreement with the K i (37 ± 2 M) measured from the kinetics experiment. Surprisingly, none of the mutants show greater than 2.5-fold effects on binding, with the exception of the Trp137Ala mutant, which abrogates the detectable fluorescence quenching signal. The two mutants that most increase affinity (about 2-fold) are Met243Ala and Arg301Lys. Interestingly, Met243 sterically clashes with the inhibitor, with the shortest distance being 3.2 Å (between pentoxifylline-N8 and Met243-Sδ-the hydrogen atom on pentoxifylline-N8 would approach Met243-Sδ even closer), and mutation to alanine relieves this clash (Figure 2) . In allosamidin, this unfavorable interaction with Met243 does not exist due to the "kink" between the two five-membered rings, whereas the pentoxifylline purine is flat ( Figure  2) . Similarly, the Arg301Lys mutant may increase binding as the flipped Trp137 indole ring closely approaches the Arg301 guanidinium group (shortest distance, 3.8 Å from Trp137-Cη2 to Arg301-Nη2; Figure 2 ). The two mutants that most decrease affinity (about 2-fold) are Asp175Ala and Ala217Gly. Ala217 forms the bottom of the pocket for the methyls on allosamidin's allosamizoline moiety; mutation to an alanine could lead to a large unoccupied pocket below the pentoxifylline purine ring. Similarly, mutation of Asp175 to Ala would cause the purine ring to bury the unsatisfied hydrogen bond donor Tyr48 (Figure 2) . Strikingly, the Y245F mutation, which removes the only direct side-chain inhibitor hydrogen bond observed in the complex, only reduces the affinity 1.5-fold (Figure 2, Table 1 ).
Discussion
Using a screening approach, several methylxanthines were identified that inhibit family 18 chitinases, the most potent being pentoxifylline, showing a K i of up to 37 M against the chitinase AfChiB1 from the fungal pathogen A. fumigatus. These molecules are small and drug-like and make extensive hydrogen bonding and π-π stacking interactions with the active site, which appear to be unique to the chitinase, as the other glycosidases tested show only poor inhibition. The largest of these inhibitors, pentoxifylline, only covers a small part of the AfChiB1 active site, from the −1 to just beyond the −2 subsite. By comparison, other more potent chitinase inhibitors, such as allosamidin (which covers the −1 to −3 subsites, Figure 2 ) and argifin/argadin (which cover the −1 to +2 subsites [18, 23] ) occupy further subsites. It should be noted that nearly all residues in the −1 subsite are identical in the "bacterial"-and "plant"-types of chitinases [35] , suggesting these inhibitors may also reduce activity of the latter class of enzymes.
Previous analyses of the binding mode of methylxanthines in the phosphodiesterases show that the N1-methyl projects into a small pocket, suggesting that there is no additional space to derivatize much beyond the pentoxifylline side chain [38, 39] . Thus, it should be possible to extend the methylxanthine scaffold to address the additional available chitinase subsites and increase chitinase affinity and selectivity through synthetically accessible purine chemistry. Molecules of this nature may help elucidate the role that chitinases play in fungal morphology, growth, and virulence. Similarly, this approach may extend to the study of the precise functions of the mammalian chitinases. In this regard, chitotriosidase and acidic mammalian chitinase, as well as several structurally related, more family 18 chitinaselike lectins (chilectins), purported to be involved in carbohydrate recognition, such as HCgp-39, YM-1, and YM-2, have been implicated in the pathophysiology of inflammation (reviewed in [40] ). Chitotriosidase is expressed in activated macrophages, and its levels are known to be upregulated both in atherosclerosis and in patients with Gaucher's lipid storage disease [26] . Acidic mammalian chitinase expression has been shown to be upregulated in the lungs of asthmatics, as well as in mice that develop airway hyperresponsiveness following antigen sensitization and challenge [12] . In the latter instance, inhibitors of AMCase (neutralizing antisera, allosamidin) efficaciously decreased airway hyperresponsiveness, reduced inflammatory cell influx into bronchiolar alveolar lavage fluid, and ameliorated airway inflammation. Anti-inflammatory effects of methylxanthine derivatives in vivo have already been well documented. For instance, theophylline has a greater than 50-year history as an asthma drug and acts not only as a bronchodilator, but also as an immunomodulator that downregulates the function of inflammatory cells in vitro and in vivo (reviewed in [41] ). Pentoxifylline, a drug used clinically to treat peripheral vascular disease, likewise has immune-modulating properties [42, 43] , including the ability to suppress inflammatory cytokine production. This drug has also been demonstrated to blunt airway hyperresponsiveness during allergen sensitization in rodent models of allergic inflammation [44] . The proposed mechanisms of action for theophylline and pentoxifylline action thought to occur at clinically relevant drug concentrations are nonspecific phosphodiesterase isozyme inhibition and nonselective antagonism of adenosine receptors [28] [29] [30] . Future research could investigate whether the methylxanthine derivatives identified here affect chitinase activity in an antiasthma setting. (Figure 2) . Due to the relatively high inhibitor concentrations used for soaking, electron density for additional, less ordered inhibitor molecules appear out with the −1 subsite. In the interest of simplicity, differences between the complexes are discussed using the first AfChiB monomer in the coordinate files, and analysis of inhibitor binding is focused on the active site only. Topologies for the ligands were obtained from the PRODRG server [48] . Images were generated with PyMol (available online at: http://www.pymol.org). AfChiB1 was screened against a small molecule library of 880 compounds (Prestwick Chemical, France). The library was screened with 50 l assay volumes in 96-well plates using 2 nM of enzyme, 0.1 mg/ml BSA, and 20 M substrate and 100 M inhibitor, assuming a compound molecular weight of 500 Da. To remove false positives of compounds that absorb at the excitation wavelength used for measuring 4MU concentration (and thus enzyme activity), absorbance at the excitation wavelength (360 nm) was also monitored.
Significance
AfChiB1 Enzymology and Mutagenesis
For the determination of the mode of inhibition of pentoxifylline, reactions followed the same protocol, using 5-30 M substrate in the presence of increasing amounts of the inhibitor. The mode of action was determined by plotting the data as Lineweaver-Burk plots, and by fitting all data to the standard competitive inhibition equation with GraFit software [49] .
A range of AfChiB1 point mutants were used to assess effects on inhibition-the construction, purification, and kinetic analysis of these mutants have been reported previously [18] . Lysozyme was assayed using the EnzCheck Lysozyme kit from Molecular Probes, as described by the manufacturer. Chicken egg white lysozyme and its substrate, fluorescein-labeled Micrococcus lysodeikyius cell wall (DQ lysozyme substrate) were used to determine compound inhibition. Briefly, 6.25 U of lysozyme were incubated with 25 g of DQ substrate with or without various concentrations of inhibitor in a total volume of 100 l at 37°C for 30 min. The fluorescence was determined using excitation and emission wavelengths of 360 and 460 nm, respectively. The IC 50 was determined from a dose-response curve. Experiments were performed in triplicate.
Gene sequences for the human chitotriosidase and AMCase are known [51, 27] . cDNAs encoding human chitotriosidase and human AMCase were generated from total human lung RNA using RT-PCR and primers based on the published sequence (primer pairs: 5#-gcc accatggtgcggtctgtggcctgggcaggtttc-3# and 5#-tcaattccaggtgcagc atttgcaggagttgctg-3# for chitotriosidase: 5#-gccaccatgacaaagctt attctcctcacaggtcttg-3# and 5#-ttatgcccagttgcagcaatcacagctggtgt cgaag-3# for AMCase), then subcloned into p3xFLAG-CMV-13 vector (Sigma). The vector encodes three adjacent FLAG epitopes downstream of the cloning region. Plasmids encoding FLAG-tagged chitotriosidase and hAMCase were then transiently transfected into HEK 293 cells and supernatants harvested 3 or 6 d after transfection. FLAG-tagged expressing proteins were purified over an anti-FLAG M2 gel affinity column and eluted with a 3XFLAG peptide according to the manufacturer's instructions. Inhibitor potencies were determined for the purified proteins using the chitinase assay similar to the one described above. Briefly, the assay consisted of fluorogenic substrate 4MU-GlcNAc 2 (Sigma) at a final concentration of 22 M, along with 1 nM of enzyme in a final volume of 100 l. The fluorescence was read using excitation and emission wavelengths of 355 and 460 nm, respectively. The buffers were the same as described above for fungal chitinase, and the reaction was carried out at 30°C for 30 min.
